Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Oncotarget
|
March 20, 2018
Research progress on the forkhead box C1
Jinhua Wang, Wan Li, Xiangjin Zheng, et al.
Annals of Translational Medicine
|
September 27, 2019
Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer
Jie Yi, Liwen Ren, Jie Wu, et al.
Acta Pharmaceutica Sinica. B
|
February 22, 2020
3-<i>O</i>-Acetyl-11-keto- <b></b> -boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma
Wan Li, Liwen Ren, Xiangjin Zheng, et al.
Acta Pharmaceutica Sinica. B
|
September 25, 2018
Ganglioside GD3 synthase (GD3S), a novel cancer drug target
Jinyi Liu, Xiangjin Zheng, Xiaocong Pang, et al.
Acta Pharmaceutica Sinica. B
|
September 2, 2024
Erratum: Author correction to '3-<i>O</i>-Acetyl-11-keto-<i>β</i>-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]
Wan Li, Liwen Ren, Xiangjin Zheng, et al.
Cell Proliferation
|
October 24, 2019
Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis
Qin Tang, Liwen Ren, Jinyi Liu, et al.
Cancer Medicine
|
October 2, 2019
Apolipoproteins and cancer
Liwen Ren, Jie Yi, Wan Li, et al.
Signal Transduction and Targeted Therapy
|
July 13, 2024
Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
Qin Tang, Wan Li, Xiangjin Zheng, et al.
Signal Transduction and Targeted Therapy
|
December 2, 2020
MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
Qin Tang, Wan Li, Xiangjin Zheng, et al.
Pharmacology & Therapeutics
|
August 24, 2017
Members of FOX family could be drug targets of cancers
Jinhua Wang, Wan Li, Ying Zhao, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Oncotarget
|
March 20, 2018
Research progress on the forkhead box C1
Jinhua Wang, Wan Li, Xiangjin Zheng, et al.
Annals of Translational Medicine
|
September 27, 2019
Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer
Jie Yi, Liwen Ren, Jie Wu, et al.
Acta Pharmaceutica Sinica. B
|
February 22, 2020
3-<i>O</i>-Acetyl-11-keto- <b></b> -boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma
Wan Li, Liwen Ren, Xiangjin Zheng, et al.
Acta Pharmaceutica Sinica. B
|
September 25, 2018
Ganglioside GD3 synthase (GD3S), a novel cancer drug target
Jinyi Liu, Xiangjin Zheng, Xiaocong Pang, et al.
Acta Pharmaceutica Sinica. B
|
September 2, 2024
Erratum: Author correction to '3-<i>O</i>-Acetyl-11-keto-<i>β</i>-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]
Wan Li, Liwen Ren, Xiangjin Zheng, et al.
Cell Proliferation
|
October 24, 2019
Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis
Qin Tang, Liwen Ren, Jinyi Liu, et al.
Cancer Medicine
|
October 2, 2019
Apolipoproteins and cancer
Liwen Ren, Jie Yi, Wan Li, et al.
Signal Transduction and Targeted Therapy
|
July 13, 2024
Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
Qin Tang, Wan Li, Xiangjin Zheng, et al.
Signal Transduction and Targeted Therapy
|
December 2, 2020
MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
Qin Tang, Wan Li, Xiangjin Zheng, et al.
Pharmacology & Therapeutics
|
August 24, 2017
Members of FOX family could be drug targets of cancers
Jinhua Wang, Wan Li, Ying Zhao, et al.
Page
of 4